Moderna’s Covid-19 vaccine may have a higher risk of heart inflammation in young men than the Pfizer/BioNTech shot, according to data by US Centers for Disease Control and Prevention.
US News website reported that according to data provided by the Vaccine Safety Data System, the risk of carditis increased among males between the ages of 18 and 39 after getting a second Moderna dose, to reach 97.3 cases per one million doses. This is compared to 81.7 cases per million doses per one million Pfizer doses.
The US Centers for Disease Control and Prevention made the announcement in conjunction with the most recent Food and Drug Organization (FDA)’s meeting to discuss the licensing of the Moderna vaccine for children and adolescents between the ages of 6 and 17 years.
The FDA pointed out that some US vaccination safety monitoring systems did not agree with the data about myocarditis and pericarditis, two types of heart inflammation linked to Moderna dosages.
It also showed that people who contract myocarditis after receiving the “Moderna” vaccine eventually recover.
